V. S. Murthy's most recent trade in Sequent Scientific Ltd. was a Acquisition of 6,250 Equity Shares done at an average price of Rs. 40 . Disclosure was reported to the exchange on July 28, 2020 under the SEBI (Prohibition of Insider Trading) Regulations, 2015.
V. S. Murthy's has made SAST transactions in SMS Pharmaceuticals Ltd. recently where a Acquisition of 3,200,000 shares done . Disclosure was reported to the exchange on Nov. 25, 2020.
Stock | Client Name | Client Category | Action* | Reported To/By Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Period | Regulation (Insider/SAST) | Security Type | Mode |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
SMS Pharmaceuticals | Vamsi Krishna Potluri, Potluri Infra Projects LLP, Potluri Laboratories Pvt Ltd, TVVSN Murthy HUF, Sudeepthi | Promoter | Acquisition | 26 Nov 2020 | 3,200,000 | 8,010,590 (9.46%) | 3.78% | - | 25 Nov 2020 25 Nov 2020 |
SAST (29(2)) | - | Market | |
Sequent Scientific | V. S. Murthy | Designated Person | Acquisition | 28 Jul 2020 | 6,250 | 6,250 (0%) | 0.00% | 40 | 250,000 | 24 Jul 2020 24 Jul 2020 |
Insider Trading | Equity Shares | ESOP |